Skip to main content
Article thumbnail
Location of Repository

JNets: Exploring networks by integrating annotation

By Jamie I MacPherson, John W Pinney and David L Robertson
Topics: Software
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2674432
Provided by: PubMed Central

Suggested articles

Citations

  1. (2000). A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature
  2. (2007). Bridge and brick network motifs: Identifying significant building blocks from complex biological systems.
  3. (2008). Cataloguing the HIV-Human Protein Interaction Network. AIDS Research and Human Retroviruses
  4. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing.
  5. (2007). D: An exploration of alternative visualisations of the basic helix-loophelix protein interaction network. BMC Bioinformatics
  6. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration.
  7. (2007). DrugBank: a knowledgebase for drugs, drug actions and drug targets.
  8. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
  9. (2002). et al.: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature
  10. (2003). Groom C: Target analysis: a priori assessment of druggability. Ernst Schering Research Foundation workshop
  11. Human immunodeficiency virus type 1, human protein interaction database at NCBI.
  12. (2003). I: Pathway studio-the analysis and navigation of molecular networks.
  13. (2003). Ideker T: Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research
  14. (1996). Identification of a major coreceptor for primary isolates of HIV-1. Nature
  15. (2001). Lethality and centrality in protein networks.
  16. (1911). Liddament M: Retroviral restriction by APOBEC proteins. Nature Reviews Immunology
  17. (1989). M: HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell
  18. (2005). Maraviroc (UK427,857), a Potent, Orally Bioavailable, and Selective SmallMolecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy
  19. (2003). Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv Exp Med Biol
  20. (2003). Mirny L: Protein complexes and functional modules in molecular networks.
  21. (2004). Morlat P: Malignancy-Related Causes of Death in Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy. Cancer
  22. (2008). Sonnhammer E: jSquid: a Java applet for graphical on-line network exploration. Bioinformatics
  23. (2004). Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity. The Journal of Experimental Medicine
  24. (2008). T: Small-molecule inhibition of HIV-1 Vif. Nature Biotechnology
  25. (2004). Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion. Microbes and Infection
  26. (1994). Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy,
  27. (1994). Trono D: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell
  28. (2000). Trono D: The Nef protein of HIV1 associates with rafts and primes T cells for activation.
  29. (2004). VisANT: an online visualization and analysis tool for biological interaction data.
  30. (2005). VisANT: data-integrating visual framework for biological networks and modules.
  31. (2004). WebInterViewer: visualizing and analyzing molecular interaction networks.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.